Europe Epigenetics Diagnostic Market Growth and Development Insight - Size, Share, Growth, and Industry Analysis| MarkNt

Comentários · 4 Visualizações

The Europe Epigenetics Diagnostic Market size was valued at around USD 5.4 billion in 2024 and is projected to reach USD 13 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 15.8% during the forecast period, i.e., 2025-30.

Europe Epigenetics Diagnostic Market Overview: 2025-2030

Base Year: 2024

Historical Years: 2020-23

Forecast Years: 2025-30

The Europe Epigenetics Diagnostic Market size was valued at around USD 5.4 billion in 2024 and is projected to reach USD 13 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 15.8% during the forecast period, i.e., 2025-30. The main reasons behind this growth are the growing demand for personalized medicines, early detection of harmful chronic diseases, reduced treatment costs, enhanced treatment efficiency, and continuous investments in research and development. This is because epigenetic diagnostics helps the healthcare providers in accurately knowing about the infecting cell and give a targeted treatment to the patient which helps in reducing the cost and precisely treating the disease. Such investments also align with regional trends of rising chronic diseases, aging populations, and increasing healthcare awareness.

Markntel Advisor’s Europe Epigenetics Diagnostic Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Europe Epigenetics Diagnostic Market drivers, barriers, Europe Epigenetics Diagnostic Market Trends, and Key Players in Europe Epigenetics Diagnostic Market.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report: https://www.marknteladvisors.com/query/request-sample/europe-epigenetics-diagnostic-market.html

Europe Epigenetics Diagnostic Market Dynamics: 2025-2030

Europe Epigenetics Diagnostic Market Driver:

Increasing Cases of Chronic Diseases Driving Market Growth – The number of cases of diseases such as cancer, heart-related diseases, nerves-related diseases, etc., are continuously increasing in this region. As per the WHO, around 20% of the deaths in Europe are caused by cancer. Also, around 32.5% of the deaths were caused by heart-related diseases in 2021. This creates a high need for detecting such problems in their earlier stages and providing the patient with personalized treatment and value-based care. This is achieved through the epigenetics diagnostic which examines the working behavior of cells and helps the healthcare provider observe the progression of treatment. This results in the increased demand for such services in Europe.

Therefore, the increasing number of chronic diseases has increased the demand for epigenetic diagnostics for early detection and personalized medication, and this trend is expected to continue in the forecast period as well

Browse Full Report with Detail Analysis - https://www.marknteladvisors.com/research-library/europe-epigenetics-diagnostic-market.html

Europe Epigenetics Diagnostic Market (2025-30): Segmentation Outlook

The market report has segmented the market into the following categories:

·       By Method

o   DNA Methylation- Market Size & Forecast 2020-2030, USD Million

o   Histone Modifications- Market Size & Forecast 2020-2030, USD Million

o   Others- Market Size & Forecast 2020-2030, USD Million

According to report, Based on the method used for epigenetics diagnosis, DNA methylation leads the market with a share of around 60%.

·       By Product & Service

o   Kits & Reagents- Market Size & Forecast 2020-2030, USD Million

§  Antibodies- Market Size & Forecast 2020-2030, USD Million

§  Chip-Sequencing Kits & Reagents- Market Size & Forecast 2020-2030, USD Million

§  Bisulfite Conversion Kits & Reagents- Market Size & Forecast 2020-2030, USD Million

§  Whole-Genome Amplification Kits & Reagents- Market Size & Forecast 2020-2030, USD Million

§  5-HMC & 5-MC Analysis Kits & Reagents- Market Size & Forecast 2020-2030, USD Million

§  Histones- Market Size & Forecast 2020-2030, USD Million

§  Others- Market Size & Forecast 2020-2030, USD Million

o   Enzymes- Market Size & Forecast 2020-2030, USD Million

§  DNA-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million

§  Protein-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million

§  Others- Market Size & Forecast 2020-2030, USD Million

o   Instruments & Accessories- Market Size & Forecast 2020-2030, USD Million

o   Software- Market Size & Forecast 2020-2030, USD Million

o   Services- Market Size & Forecast 2020-2030, USD Million

According to report, Based on the type of product and service, kits & reagents dominate the market with a share of around 49%.

·       By Technique

o   NGS- Market Size & Forecast 2020-2030, USD Million

o   PCR & qPCR- Market Size & Forecast 2020-2030, USD Million

o   Mass Spectrometry- Market Size & Forecast 2020-2030, USD Million

o   Sonication- Market Size & Forecast 2020-2030, USD Million

o   Others- Market Size & Forecast 2020-2030, USD Million

·       By Application

o   Oncology- Market Size & Forecast 2020-2030, USD Million

o   Metabolic Diseases- Market Size & Forecast 2020-2030, USD Million

o   Immunology- Market Size & Forecast 2020-2030, USD Million

o   Development Biology- Market Size & Forecast 2020-2030, USD Million

o   Cardiovascular Diseases- Market Size & Forecast 2020-2030, USD Million

o   Others- Market Size & Forecast 2020-2030, USD Million

·       By End-User

o   Academic & Research Institutes- Market Size & Forecast 2020-2030, USD Million

o   Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2020-2030, USD Million

o   Hospitals & Clinics- Market Size & Forecast 2020-2030, USD Million

o   Others- Market Size & Forecast 2020-2030, USD Million

·       By Country

o   The UK

o   Germany

o   France

o   Italy

o   Spain

o   The Netherlands

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Europe Epigenetics Diagnostic Market:

  • Diagenode
  • Oncgnostics
  • Epigenomics AG
  • PerkinElmer
  • Roche Sequencing Solutions
  • EpiCypher
  • Cambridge Epigenetix
  • Promega
  • QIAGEN
  • Agilent
  • Bio-Rad
  • Pacific Biosciences

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Comentários